Form 4: Credo Director Sells $4M+ in Shares via 10b5-1 Plan
Insider Transaction Report
Credo Technology Group Director Lip-Bu Tan sold 25,000 ordinary shares for approximately $4.05 million through a pre-arranged Rule 10b5-1 trading plan.
Summary
- Lip-Bu Tan, a Director of Credo Technology Group Holding Ltd (CRDO), reported the sale of 25,000 ordinary shares.
- The transactions occurred on September 12, 2025, under a Rule 10b5-1 trading plan.
- The first sale involved 11,572 shares at a weighted average price of $161.5278 per share, totaling approximately $1,871,000.
- The second sale involved 13,428 shares at a weighted average price of $162.3665 per share, totaling approximately $2,180,000.
- The total value of shares sold across both transactions is approximately $4,051,000.
- These sales were indirect, executed through Walden Technology Ventures II LP, where Lip-Bu Tan is the Managing Director of the general partner.
- Following these transactions, Walden Technology Ventures II LP beneficially owns 442,180 ordinary shares.
- Lip-Bu Tan also indirectly holds 133,583 shares through the Lip-Bu Tan and Ysa Loo Trust and 39,736 shares through A&E Investment LLC, and directly holds 53,574 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While insider sales can sometimes be viewed negatively, the execution under a pre-arranged Rule 10b5-1 plan mitigates concerns that the sale is based on new, adverse material non-public information. It represents a planned liquidity event rather than a reactive one.
Positives
- The transactions were executed under a Rule 10b5-1 trading plan, indicating that the sales were pre-scheduled and not based on new material non-public information, which enhances transparency and reduces concerns about opportunistic insider selling.
Negatives
- A director selling a significant number of shares (25,000 shares for over $4 million) could be perceived negatively by some investors, potentially signaling a lack of confidence in the company's near-term prospects, despite the 10b5-1 plan.
Future Outlook
This Form 4 filing is a report of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing reports a routine insider transaction and does not provide information that directly relates to broader industry trends or competitive landscape analysis.
Related Party Transactions
- The sales were conducted indirectly through Walden Technology Ventures II LP, where the reporting person, Lip-Bu Tan, is the Managing Director of its general partner. He disclaims beneficial ownership except to the extent of any pecuniary interest.
- Lip-Bu Tan also has indirect beneficial ownership through the Lip-Bu Tan and Ysa Loo Trust (where he is a joint trustee) and A&E Investment LLC (where he is the Manager and it is owned by his family trust).
Stakeholder Impact
- Shareholders may interpret the director's sale of shares differently; however, the pre-planned nature via a 10b5-1 plan typically reduces the negative signal often associated with insider selling, suggesting it's for personal financial planning rather than a reflection of company performance.
Key Dates
| Date | Description |
|---|---|
| 09/12/2025 | Date of share transactions by Lip-Bu Tan. |
| 09/16/2025 | Date the Form 4 was signed by attorney-in-fact James Laufman. |
Recommendation
holdThe director's sale of shares was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned transaction rather than a reaction to new material non-public information. While insider sales can sometimes signal a lack of confidence, the pre-planned nature mitigates this concern, suggesting a 'hold' recommendation as it doesn't fundamentally alter the investment thesis based solely on this transaction.
Keywords
Credo Technology Group, CRDO, Lip-Bu Tan, Insider Sale, Form 4, Equity Transaction, Director Sale, 10b5-1 Plan, Share Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.